143 related articles for article (PubMed ID: 12667668)
1. Humanization of an anti-ICAM-1 antibody with over 50-fold affinity and functional improvement.
Luo GX; Kohlstaedt LA; Charles CH; Gorfain E; Morantte I; Williams JH; Fang F
J Immunol Methods; 2003 Apr; 275(1-2):31-40. PubMed ID: 12667668
[TBL] [Abstract][Full Text] [Related]
2. Virolysis and in vitro neutralization of HIV-1 by humanized monoclonal antibody hNM-01.
Nakamura M; Terada M; Sasaki H; Kamada M; Ohno T
Hybridoma; 2000 Dec; 19(6):427-34. PubMed ID: 11152394
[TBL] [Abstract][Full Text] [Related]
3. Humanization of a mouse monoclonal antibody that blocks the epidermal growth factor receptor: recovery of antagonistic activity.
Mateo C; Moreno E; Amour K; Lombardero J; Harris W; Pérez R
Immunotechnology; 1997 Mar; 3(1):71-81. PubMed ID: 9154469
[TBL] [Abstract][Full Text] [Related]
4. Humanization of the anti-CD18 antibody 6.7: an unexpected effect of a framework residue in binding to antigen.
Caldas C; Coelho V; Kalil J; Moro AM; Maranhão AQ; Brígido MM
Mol Immunol; 2003 May; 39(15):941-52. PubMed ID: 12695120
[TBL] [Abstract][Full Text] [Related]
5. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
Wu H; Nie Y; Huse WD; Watkins JD
J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
[TBL] [Abstract][Full Text] [Related]
6. Identification of monoclonal antibody epitopes and critical residues for rhinovirus binding in domain 1 of intercellular adhesion molecule 1.
McClelland A; deBear J; Yost SC; Meyer AM; Marlor CW; Greve JM
Proc Natl Acad Sci U S A; 1991 Sep; 88(18):7993-7. PubMed ID: 1716769
[TBL] [Abstract][Full Text] [Related]
7. Humanization of an anti-CD34 monoclonal antibody by complementarity-determining region grafting based on computer-assisted molecular modelling.
Hou S; Li B; Wang L; Qian W; Zhang D; Hong X; Wang H; Guo Y
J Biochem; 2008 Jul; 144(1):115-20. PubMed ID: 18424812
[TBL] [Abstract][Full Text] [Related]
8. Use of human germline genes in a CDR homology-based approach to antibody humanization.
Hwang WY; Almagro JC; Buss TN; Tan P; Foote J
Methods; 2005 May; 36(1):35-42. PubMed ID: 15848073
[TBL] [Abstract][Full Text] [Related]
9. Viral receptor blockage by multivalent recombinant antibody fusion proteins: inhibiting human rhinovirus (HRV) infection with CFY196.
Fang F; Yu M
J Antimicrob Chemother; 2004 Jan; 53(1):23-5. PubMed ID: 14657090
[TBL] [Abstract][Full Text] [Related]
10. Humanization by variable domain resurfacing and grafting on a human IgG4, using a new approach for determination of non-human like surface accessible framework residues based on homology modelling of variable domains.
Staelens S; Desmet J; Ngo TH; Vauterin S; Pareyn I; Barbeaux P; Van Rompaey I; Stassen JM; Deckmyn H; Vanhoorelbeke K
Mol Immunol; 2006 Mar; 43(8):1243-57. PubMed ID: 16118019
[TBL] [Abstract][Full Text] [Related]
11. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
[TBL] [Abstract][Full Text] [Related]
12. Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions.
Finlay WJ; Cunningham O; Lambert MA; Darmanin-Sheehan A; Liu X; Fennell BJ; Mahon CM; Cummins E; Wade JM; O'Sullivan CM; Tan XY; Piche N; Pittman DD; Paulsen J; Tchistiakova L; Kodangattil S; Gill D; Hufton SE
J Mol Biol; 2009 May; 388(3):541-58. PubMed ID: 19285987
[TBL] [Abstract][Full Text] [Related]
13. Humanization of an anti-lymphocyte function-associated antigen (LFA)-1 monoclonal antibody and reengineering of the humanized antibody for binding to rhesus LFA-1.
Werther WA; Gonzalez TN; O'Connor SJ; McCabe S; Chan B; Hotaling T; Champe M; Fox JA; Jardieu PM; Berman PW; Presta LG
J Immunol; 1996 Dec; 157(11):4986-95. PubMed ID: 8943405
[TBL] [Abstract][Full Text] [Related]
14. Human-engineered monoclonal antibodies retain full specific binding activity by preserving non-CDR complementarity-modulating residues.
Studnicka GM; Soares S; Better M; Williams RE; Nadell R; Horwitz AH
Protein Eng; 1994 Jun; 7(6):805-14. PubMed ID: 7937712
[TBL] [Abstract][Full Text] [Related]
15. Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomas.
Mersmann M; Schmidt A; Rippmann JF; Wüest T; Brocks B; Rettig WJ; Garin-Chesa P; Pfizenmaier K; Moosmayer D
Int J Cancer; 2001 Apr; 92(2):240-8. PubMed ID: 11291052
[TBL] [Abstract][Full Text] [Related]
16. An anti-human ICAM-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation.
Traub S; Nikonova A; Carruthers A; Dunmore R; Vousden KA; Gogsadze L; Hao W; Zhu Q; Bernard K; Zhu J; Dymond M; McLean GR; Walton RP; Glanville N; Humbles A; Khaitov M; Wells T; Kolbeck R; Leishman AJ; Sleeman MA; Bartlett NW; Johnston SL
PLoS Pathog; 2013; 9(8):e1003520. PubMed ID: 23935498
[TBL] [Abstract][Full Text] [Related]
17. Molecular modeling and preclinical evaluation of the humanized NR-LU-13 antibody.
Graves SS; Goshorn SC; Stone DM; Axworthy DB; Reno JM; Bottino B; Searle S; Henry A; Pedersen J; Rees AR; Libby RT
Clin Cancer Res; 1999 Apr; 5(4):899-908. PubMed ID: 10213227
[TBL] [Abstract][Full Text] [Related]
18. Design and Generation of Humanized Single-chain Fv Derived from Mouse Hybridoma for Potential Targeting Application.
Khantasup K; Chantima W; Sangma C; Poomputsa K; Dharakul T
Monoclon Antib Immunodiagn Immunother; 2015 Dec; 34(6):404-17. PubMed ID: 26683180
[TBL] [Abstract][Full Text] [Related]
19. Expression and characterization of a humanized cocaine-binding antibody.
Redwan el-RM; Larsen NA; Zhou B; Wirsching P; Janda KD; Wilson IA
Biotechnol Bioeng; 2003 Jun; 82(5):612-8. PubMed ID: 12652485
[TBL] [Abstract][Full Text] [Related]
20. SDR grafting--a new approach to antibody humanization.
Kashmiri SV; De Pascalis R; Gonzales NR; Schlom J
Methods; 2005 May; 36(1):25-34. PubMed ID: 15848072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
